Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06328673 |
| Title | A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | D2M Biotherapeutics Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| NEXT Oncology | RECRUITING | San Antonio | Texas | 78216 | United States | Details |
| The Cancer Institute and Hospital, Chinese Academy of Medical Sciences(CAMS) | RECRUITING | Beijing | China | Details |